Mongo Research

GLP - 3RT

Triple GLP-1 / GIP / glucagon receptor agonist · identity-verified

GLP - 3RT (retatrutide) is a triple receptor agonist peptide that targets the GLP-1, GIP, and glucagon receptors — a single molecule acting on three metabolic pathways. It is studied in research on metabolic regulation, energy balance, and receptor pharmacology. Retatrutide is an investigational compound and is not FDA-approved; published human data comes from ongoing clinical trials. Every Mongo Research batch is identity- and purity-confirmed by HPLC and mass spectrometry, and the batch number on the vial matches a publicly searchable Certificate of Analysis from Freedom Diagnostics. With a compound this potent, confirming exactly what is in the vial — the identity of the peptide, not just a purity percentage — is what separates a research-grade source from a guess. Don't trust us; verify the batch yourself. For research use only. Not for human consumption.